NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
21 hedge funds and large institutions have $34.1M invested in NeuroDerm Ltd. Ordinary Shares in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
61% more capital invested
Capital invested by funds: $21.2M → $34.1M (+$12.9M)
40% more funds holding
Funds holding: 15 → 21 (+6)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$5.22M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.77M |
| 3 |
MMH
Menora Mivtachim Holdings
Ramat Gan,
Israel
|
+$1.5M |
| 4 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
+$1.05M |
| 5 |
PVI
Pura Vida Investments
New York
|
+$746K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.11M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$698K |
| 3 |
EEG
E.E. Geduld
|
-$470K |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$27K |
| 5 |
OC
Oppenheimer & Co
New York
|
-$14K |
NDRM Hedge Fund Activity: Q2 2015 in Review
21 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q2 2015, worth a combined $34.1M — up 61% from $21.2M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NDRM positions and 3 closed out — a net gain of 6 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $5.22M. The largest seller was Perceptive Advisors, cutting an estimated $2.11M.
- 21 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q2 2015, up from 15 in Q1 2015.
- Funds reported $34.1M of NeuroDerm Ltd. Ordinary Shares stock for Q2 2015, up 61% quarter-over-quarter.
- 9 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q2 2015 and 3 closed out, a net change of +6 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q2 2015 was Avoro Capital Advisors, an estimated $5.22M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q2 2015 was Perceptive Advisors, an estimated $2.11M sold.
Based on aggregated 13F filings for Q2 2015.